Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- 1-Phosphatidylinositol 4-Kinase antagonists & inhibitors MeSH
- Antiviral Agents chemistry pharmacology MeSH
- HeLa Cells MeSH
- Enzyme Inhibitors chemistry pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- Drug Design MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 1-Phosphatidylinositol 4-Kinase MeSH
- Antiviral Agents MeSH
- Enzyme Inhibitors MeSH
Phosphatidylinositol 4-kinase IIIβ (PI4KB) is indispensable for the replication of various positive-sense single stranded RNA viruses, which hijack this cellular enzyme to remodel intracellular membranes of infected cells to set up the functional replication machinery. Therefore, the inhibition of this PI4K isoform leads to the arrest of viral replication. Here, we report on the synthesis of novel PI4KB inhibitors, which were rationally designed based on two distinct structural types of inhibitors that bind in the ATP binding side of PI4KB. These "hybrids" not only excel in outstanding inhibitory activity but also show high selectivity to PI4KB compared to other kinases. Thus, these compounds exert selective nanomolar or even subnanomolar activity against PI4KB as well as profound antiviral effect against hepatitis C virus, human rhinovirus, and coxsackievirus B3. Our crystallographic analysis unveiled the exact position of the side chains and explains their extensive contribution to the inhibitory activity.
References provided by Crossref.org
Crystal Structure of the ORP8 Lipid Transport ORD Domain: Model of Lipid Transport
Structural basis for SARS-CoV-2 nucleocapsid (N) protein recognition by 14-3-3 proteins
The Present and Future of Virology in the Czech Republic-A New Phoenix Made of Ashes?
Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease
Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß
Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites